advertisement
Schwartz GF 8
Showing records 1 to 8 | Display all abstracts from Schwartz GF92570 A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting
Zaman F
Current Medical Research and Opinion 2021; 37: 1011-1020
92044 Economic and Clinical Burden Associated With Intensification of Glaucoma Topical Therapy: A US Claims-based Analysis
Patel AR; Schwartz GF
Journal of Glaucoma 2021; 30: 242-250
92570 A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting
Gieser SC; Schwartz GF
Current Medical Research and Opinion 2021; 37: 1011-1020
92044 Economic and Clinical Burden Associated With Intensification of Glaucoma Topical Therapy: A US Claims-based Analysis
Campbell JH; Chen CC
Journal of Glaucoma 2021; 30: 242-250
92570 A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting
Swan C
Current Medical Research and Opinion 2021; 37: 1011-1020
92044 Economic and Clinical Burden Associated With Intensification of Glaucoma Topical Therapy: A US Claims-based Analysis
McGuiness CB
Journal of Glaucoma 2021; 30: 242-250
92570 A multicenter, open-label study of netarsudil for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension in a real-world setting
Williams JM
Current Medical Research and Opinion 2021; 37: 1011-1020
92044 Economic and Clinical Burden Associated With Intensification of Glaucoma Topical Therapy: A US Claims-based Analysis
McGuiness CB; Multani JK; Multani JK; Shih V; Shih V; Shih V; Smith OU
Journal of Glaucoma 2021; 30: 242-250
